Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests: Creation of the Variant Task Force Genotyping Assay - POCTRN

null Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests: Creation of the Variant Task Force Genotyping Assay

Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests

On February 25, 2022, The RADx initiative created a Variant Task Force (VTF) to assess the impact of emerging SARS-CoV-2 variants on diagnostic testing.


The NIH’s RADx initiative created a Variant Task Force (VTF) in January 2021 to assess the impact of emerging SARS-CoV-2 variants on in vitro diagnostic testing. In July 2021, the RADx VTF initiated an effort to develop a SARS-CoV-2 Polymerase Chain Reaction assay for variant agnostic detection of SARS-CoV-2, as well as early detection and monitoring of SARS-CoV-2 variants.

The aims of this project were to:

  1. Identify SARS-CoV-2 markers useful for the detection of SARS-CoV-2 positive samples across all variants
  2. Develop a panel of SNP markers that can be used to accurately assign lineages to SARS-CoV-2 positive samples
  3. Implement a genotyping approach for the early detection of new and re-emerging variants that signals when markers need to be updated.

Speakers

Richard S. Creager, PhD 
RADx Team Leader

Eric Lai, PhD 
RADx Team Leader

When: 

February 15, 2022, 2PM ET

Watch the webinar >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19